Stock Events

Stock Events

ExpreS2ion Biotech AB 

0
0
+SEK0.00+0% 00:00 Today

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

Nov 12Expected
Q1 2026
Q2 2026
Next
999
333
-333
-999
Expected EPS
N/A
Actual EPS
N/A

Financials

-1,041.43%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
3.66MRevenue
-38.09MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow EXPRS2-BT-UN.ST. It's not an investment recommendation.
Novo Nordisk
5
NOVO-B.CO
Bavarian Nordic A/S
3
BAVA.CO
Vestas Wind Systems AS
2
VWS.CO

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Novavax
NVAX
Mkt Cap1.66B
Novavax is a biotechnology company developing vaccines, including for infectious diseases, directly competing with ExpreS2ion's focus on vaccine development.
Moderna
MRNA
Mkt Cap88.52B
Moderna is known for its mRNA technology used in vaccines, similar to ExpreS2ion's work on novel vaccine platforms.
BioNTech
BNTX
Mkt Cap22.15B
BioNTech competes in the space of developing vaccines using mRNA technology, similar to ExpreS2ion's focus areas.
Pfizer
PFE
Mkt Cap173.95B
Pfizer, in collaboration with BioNTech, has developed mRNA vaccines, placing it in direct competition with ExpreS2ion's vaccine development efforts.
Johnson & Johnson
JNJ
Mkt Cap657.68B
Johnson & Johnson develops vaccines, including for infectious diseases, making it a competitor in the same market as ExpreS2ion.
Astrazeneca
AZN
Mkt Cap289.48B
AstraZeneca is involved in developing vaccines for various diseases, competing with ExpreS2ion's efforts in vaccine development.
GSK
GSK
Mkt Cap99.19B
GlaxoSmithKline works on vaccines and therapeutics, including for infectious diseases, competing with ExpreS2ion's vaccine development projects.
Sanofi
SNY
Mkt Cap106.24B
Sanofi is engaged in vaccine development and production, making it a competitor in the same field as ExpreS2ion.
Inovio Pharmaceuticals
INO
Mkt Cap62.29M
Inovio Pharmaceuticals is involved in the development of DNA vaccines, a technology that competes with ExpreS2ion's vaccine development platforms.

About

Based in Horsholm, Denmark, ExpreS2ion Biotech Holding AB, along with its subsidiary ExpreS2ion Biotechnologies, specializes in creating and manufacturing complex proteins for use in vaccines and diagnostic products. The company's development pipeline includes a capsid virus-like particle COVID-19 vaccine, an influenza vaccine, and a breast cancer vaccine, all of which are currently undergoing Phase II clinical trials. ExpreS2ion is also engaged in developing a malaria vaccine. Furthermore, the company extends its reach by licensing its proprietary ExpreS2 platform to various research organizations and pharmaceutical businesses. ExpreS2ion Biotech Holding AB commenced operations in 2015.
Show More
CEO
Bent U. Frandsen
Employees
19
Country
Sweden
ISIN
SE0028501155

Listings

MU
DE
5JD.MU
ST
SE
EXPRS2-BT-UN.ST
STU
DE
5JD0.STU
MU
DE
5JD0.MU

0 Comments

Share your thoughts

FAQs

What is ExpreS2ion Biotech AB stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Stockholm Exchange exchange ExpreS2ion Biotech AB stocks are traded under the ticker EXPRS2-BT-UN.ST.
When is the next ExpreS2ion Biotech AB earnings date?▼
ExpreS2ion Biotech AB is going to release the next earnings report on November 12, 2026.
What is ExpreS2ion Biotech AB revenue for the last year?▼
ExpreS2ion Biotech AB revenue for the last year amounts to 3.66M SEK.
What is ExpreS2ion Biotech AB net income for the last year?▼
EXPRS2-BT-UN.ST net income for the last year is -38.09M SEK.
How many employees does ExpreS2ion Biotech AB have?▼
As of November 3, 2026, the company has 19 employees.
In which sector is ExpreS2ion Biotech AB located?▼
ExpreS2ion Biotech AB operates in the Health & Wellness sector.
When did ExpreS2ion Biotech AB complete a stock split?▼
ExpreS2ion Biotech AB has not had any recent stock splits.
Where is ExpreS2ion Biotech AB headquartered?▼
ExpreS2ion Biotech AB is headquartered in Helsingborg, Sweden.